SCHEMBL28577936

SCHEMBL28577936

CN(C)C(=O)C=CCCCC(N)=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 1/20 0.47
FAAH O00519 3/20 0.46
SOAT1 P35610 2/20 0.46
KMT2A Q03164 2/20 0.46
MEN1 O00255 1/20 0.46
TP53 P04637 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2C19 P33261 1/20 0.46
CHRNB2 P17787 1/20 0.44
CHRNB4 P30926 1/20 0.44
CHRNA3 P32297 1/20 0.44
CHRNA4 P43681 1/20 0.44
KDM4E B2RXH2 2/20 0.42
ALDH1A1 P00352 2/20 0.34
MAPT P10636 1/20 0.34
PPARG P37231 3/20 0.33
PPARA Q07869 3/20 0.33
TOP1 P11387 2/20 0.32
F7 P08709 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29394029 0.84 CHRNB2 (0.44) CNR1FAAHSOAT1KMT2AMEN1
SCHEMBL21702922 0.84 PPARG (0.48) FAAHKMT2AMEN1TP53CYP1A2
SCHEMBL4572723 0.82 CHRNB2 (0.46) FAAHSOAT1KMT2AMEN1TP53
SCHEMBL31253415 0.81 CNR1 (0.49) CNR1FAAHSOAT1KMT2AMEN1
SCHEMBL23139471 0.79 CHRNB2 (0.47) CYP1A2CYP2C19CHRNB2CHRNB4CHRNA3
SCHEMBL29498992 0.79 CHRNB2 (0.47) CYP1A2CYP2C19CHRNB2CHRNB4CHRNA3
SCHEMBL8936205 0.79 CHRNB2 (0.47) CHRNB2CHRNB4CHRNA3CHRNA4ALDH1A1
SCHEMBL13058103 0.77 CNR1 (0.47) CNR1FAAHSOAT1KMT2AMEN1
SCHEMBL30203270 0.76 CNR1 (0.50) CNR1FAAHSOAT1KMT2AMEN1
SCHEMBL8699814 0.76 PPARG (0.51) FAAHSOAT1KMT2AMEN1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112789040-A Transglutaminase 2(TG2) inhibitors 思达利医药公司 2021-05-11 CN claimed
CN-112789040-A Transglutaminase 2(TG2) inhibitors 思达利医药公司 2021-05-11 CN disclosed